Enveric BiosciencesENVB
13F holders, Q1 2024 (March 31)18holders
1famous investor
$1.00avg. 13F price*
At the end of Q1 2024, 18 institutions reported holding Enveric Biosciences Inc. (ENVB) in their 13F filings. The largest holders were AdvisorShares Investments LLC ($239K), HRT Financial LP ($63K) and Citadel Advisors ($40K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Enveric Biosciences Inc.
- CUSIP
- 29405E208
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $171K |
| Exits | 2 | $355K |
Ownership 18 holders
| AdvisorShares Investments LLC | 0.04% | Add +68.4% | 238,833 | $239K |
| HRT Financial LP | 0.00% | New | 63,026 | $63K |
| Citadel Advisors | 0.00% | New | 40,104 | $40K |
| Virtu Financial LLC | 0.00% | New | 33,835 | $34K |
| BlackRock Inc. | 0.00% | No change | 29,578 | $30K |
| Susquehanna International Group, LLP | 0.00% | New | 18,247 | $18K |
| Vanguard Group Inc. | 0.00% | No change | 18,198 | $18K |
| Two Sigma Investments, LP | 0.00% | New | 15,397 | $15K |
| Geode Capital Management, LLC | 0.00% | No change | 13,118 | $13K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -3.1% | 12,277 | $12K |
| UBS Group AG | 0.00% | Add +49730.0% | 4,983 | $5K |
| Group One Trading LLC | 0.00% | No change | 273 | $273 |
| Osaic Holdings, Inc. | 0.00% | No change | 150 | $150 |
| Bank of America Corp. | 0.00% | No change | 100 | $100 |
| National Bank of Canada | 0.00% | No change | 70 | $63 |
| Wells Fargo & Company | 0.00% | Add +12.1% | 37 | $37 |
| Morgan Stanley | 0.00% | No change | 1 | $1 |
| Acadian Asset Management LLC | 0.00% | No change | 259 | $0 |
"% of holder's portfolio" is ENVB's weight in each manager's 13F, not the share of Enveric Biosciences Inc. the manager owns.